Revelation Biosciences Inc (REVB) Stock Price, Quote & News

Company Profile

Revelation Biosciences, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed...

Industry: Biotechnology

Sector: Healthcare

Phone: 650 800 3717

Website: www.revbiosciences.com

Address:

4660 La Jolla Village Drive, Suite 100, San Diego, United States

SimSimBola Dec. 22 at 3:06 PM

$REVB ticker trading as if FDA told them to fuq off

0 · Reply

AlwaysLearning72 Dec. 21 at 4:14 PM

$REVB hopefully we receive some positive news from their FDA meeting soon

1 · Reply

SimSimBola Dec. 19 at 3:56 PM

$REVB

0 · Reply

revuelto Dec. 18 at 8:18 PM

$REVB sell the pop, short the ….you know the drill…anyone who’s done some study here can see this is a sham operation ✌️

1 · Reply

revuelto Dec. 15 at 7:50 PM

$REVB it has to close above $1, if it doesn’t, likely heading much lower i.e. short it ✌️

1 · Reply

Love_To_Learn Dec. 15 at 1:26 PM

$REVB ive changed your 1.18 1.17 res btw so take note of that longs * place it on your chart detour of sorts

1 · Reply

thatboytrades Dec. 13 at 1:32 AM

$REVB holding a nice chunk of long position here

0 · Reply

SPYmyQQQ Dec. 12 at 12:33 AM

🎯 Target Hit 🏁 📨 From Nov 6, 2025 💊 $REVB 💵 Entry: $1.0000 ✅ Ext: $1.1900 💰 P/L: +19.00% 👉 FREE TRIAL! spymyqqq/join/

0 · Reply

dantervg Dec. 11 at 9:28 PM

$REVB people need to stop selling, hold your shares, patience is key here.

0 · Reply

revuelto Dec. 11 at 6:51 PM

$REVB get ready for a run…you’ll be in before the crowd….once it pops, take advantage of the short setup 😀

0 · Reply

Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting

Nov 20, 2025, 9:00 AM EST - 5 weeks ago

Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year

Nov 6, 2025, 4:15 PM EST - 7 weeks ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025

Oct 29, 2025, 9:00 AM EDT - 2 months ago

Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date

Oct 15, 2025, 5:00 PM EDT - 2 months ago

Revelation Biosciences Inc. Announces Adjournment of October 15, 2025 Special Meeting of Stockholders to October 29, 2025

Sep 11, 2025, 8:30 AM EDT - 3 months ago

Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds

Sep 10, 2025, 7:20 AM EDT - 3 months ago

Revelation Biosciences Announces Special Webcast to Review Positive Top-line Clinical Data

Sep 9, 2025, 4:55 PM EDT - 3 months ago

Reminder - Webcast/Conference Call to Discuss Fantastic PRIME Phase 1b Top-line Data

Sep 9, 2025, 8:00 AM EDT - 3 months ago

Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical Study

Aug 8, 2025, 6:30 AM EDT - 4 months ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2025

Jul 24, 2025, 9:00 AM EDT - 5 months ago

Revelation Biosciences, Inc. Congratulates Its Former Chairman of the Board, George Tidmarsh, on His Appointment as the Head of the FDA Center for Drug Evaluation and Research

Jul 16, 2025, 9:00 AM EDT - 5 months ago

Revelation Biosciences Inc. Completes Dosing of Patients in PRIME Study

Jul 1, 2025, 5:26 PM EDT - 6 months ago

Revelation Biosciences Inc. Announces 1-for-3 Reverse Stock Split Effective July 7, 2025

May 29, 2025, 4:05 PM EDT - 7 months ago

Revelation Biosciences, Inc. Announces Closing of $4 Million Public Offering

May 29, 2025, 8:00 AM EDT - 7 months ago

Revelation Biosciences, Inc. Announces Pricing of $4 Million Public Offering

May 23, 2025, 4:05 PM EDT - 7 months ago

Revelation Biosciences Announces Retirement of George Tidmarsh, MD, PhD from Board of Directors

May 8, 2025, 4:15 PM EDT - 8 months ago

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2025

Apr 29, 2025, 9:00 AM EDT - 8 months ago

Revelation Biosciences to Develop Gemini for Infection in Severe Burn Patients

Mar 17, 2025, 6:00 AM EDT - 10 months ago

Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells

Mar 13, 2025, 6:00 AM EDT - 10 months ago

Revelation Biosciences to Host Fireside Chat at 37th Annual Roth Conference

Mar 6, 2025, 4:15 PM EST - 10 months ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2024

Feb 26, 2025, 6:00 AM EST - 10 months ago

Revelation Biosciences Doses First Patient in PRIME Phase 1b Clinical Study of Gemini in CKD Patients

Feb 24, 2025, 6:00 AM EST - 10 months ago

Revelation Biosciences, Inc. Receives Continued NASDAQ Listing Approval

Jan 24, 2025, 6:00 AM EST - 11 months ago

Revelation Biosciences Inc. Announces 1-for-16 Reverse Stock Split Effective January 28, 2025

Jan 21, 2025, 6:00 AM EST - 1 year ago

Revelation Biosciences Starts its PRIME Phase 1b Clinical Study of Gemini in CKD Patients

Jan 13, 2025, 6:00 AM EST - 1 year ago

Revelation Biosciences Inc. Reminds You to Vote for the Special Meeting on January 17, 2025

Jan 6, 2025, 6:00 AM EST - 1 year ago

Nasdaq Grants Revelation Biosciences Inc. Continued Listing

Dec 3, 2024, 8:38 AM EST - 1 year ago

Revelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross Proceeds

Dec 2, 2024, 6:00 AM EST - 1 year ago

Revelation Biosciences Inc. Announces FDA Acceptance of Gemini IND

Nov 12, 2024, 6:00 AM EST - 1 year ago

Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply

Nov 8, 2024, 4:15 PM EST - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024

Sep 24, 2024, 6:00 AM EDT - 1 year ago

Revelation Biosciences' Gemini Induces Dose Dependent Significant Increases in IL-10

Aug 21, 2024, 5:30 PM EDT - 1 year ago

Revelation Biosciences Inc. Announces Exercise of Warrants for $3.8 Million in Gross Proceeds

Aug 9, 2024, 4:15 PM EDT - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2024

Jun 24, 2024, 9:00 AM EDT - 1 year ago

Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity

Jun 13, 2024, 9:21 AM EDT - 1 year ago

Revelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of Gemini

May 10, 2024, 4:52 PM EDT - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024

Mar 22, 2024, 4:15 PM EDT - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023

Mar 13, 2024, 9:00 AM EDT - 1 year ago

Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)

Mar 12, 2024, 9:00 AM EDT - 1 year ago

Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference

Mar 4, 2024, 9:00 AM EST - 1 year ago

Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini

Feb 13, 2024, 9:00 AM EST - 2 years ago

Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)

Feb 9, 2024, 8:35 AM EST - 2 years ago

Top 5 Health Care Stocks That Are Preparing To Pump In February

CNSP GILD ZLAB

Feb 5, 2024, 4:41 PM EST - 2 years ago

Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering

Feb 1, 2024, 6:00 AM EST - 2 years ago

Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering

Jan 30, 2024, 9:00 AM EST - 2 years ago

Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)

Jan 23, 2024, 9:00 AM EST - 2 years ago

Revelation Biosciences Inc. Announces 1-for-30 Reverse Stock Split Effective January 25, 2024

Nov 13, 2023, 4:05 PM EST - 2 years ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2023

Oct 12, 2023, 9:00 AM EDT - 2 years ago

Gemini Induces Pharmacologic Activity and Related Physiologic Changes in Multiple Preclinical Studies

Oct 4, 2023, 9:00 AM EDT - 2 years ago

Revelation Biosciences, Inc. to Present at the 2023 ROTH Healthcare Opportunities Conference

SimSimBola Dec. 22 at 3:06 PM

$REVB ticker trading as if FDA told them to fuq off

0 · Reply

AlwaysLearning72 Dec. 21 at 4:14 PM

$REVB hopefully we receive some positive news from their FDA meeting soon

1 · Reply

SimSimBola Dec. 19 at 3:56 PM

$REVB

0 · Reply

revuelto Dec. 18 at 8:18 PM

$REVB sell the pop, short the ….you know the drill…anyone who’s done some study here can see this is a sham operation ✌️

1 · Reply

revuelto Dec. 15 at 7:50 PM

$REVB it has to close above $1, if it doesn’t, likely heading much lower i.e. short it ✌️

1 · Reply

Love_To_Learn Dec. 15 at 1:26 PM

$REVB ive changed your 1.18 1.17 res btw so take note of that longs * place it on your chart detour of sorts

1 · Reply

thatboytrades Dec. 13 at 1:32 AM

$REVB holding a nice chunk of long position here

0 · Reply

SPYmyQQQ Dec. 12 at 12:33 AM

🎯 Target Hit 🏁 📨 From Nov 6, 2025 💊 $REVB 💵 Entry: $1.0000 ✅ Ext: $1.1900 💰 P/L: +19.00% 👉 FREE TRIAL! spymyqqq/join/

0 · Reply

dantervg Dec. 11 at 9:28 PM

$REVB people need to stop selling, hold your shares, patience is key here.

0 · Reply

revuelto Dec. 11 at 6:51 PM

$REVB get ready for a run…you’ll be in before the crowd….once it pops, take advantage of the short setup 😀

0 · Reply

Greyghost013 Dec. 11 at 6:01 PM

$REVB very interesting movement today

0 · Reply

Greyghost013 Dec. 11 at 3:23 PM

$REVB some volume would push this back to 2

0 · Reply

tommy_john Dec. 11 at 12:05 AM

$REVB this turned up. $1.20 breakout is needed.

0 · Reply

dbr_island Dec. 10 at 9:48 PM

$REVB watching.. 🚨ENSC🚨loading

1 · Reply

SimSimBola Dec. 9 at 6:58 PM

$REVB

0 · Reply

revuelto Dec. 9 at 6:53 PM

$REVB direct flight to pumpville… the higher it goes the better..

0 · Reply

Cypherr Dec. 9 at 12:25 PM

$REVB what do we have here…

1 · Reply

revuelto Dec. 8 at 10:17 PM

$REVB you’ll likely see a 1x maybe even a 2x but don’t miss the chance to short when it happens 😀

0 · Reply

Chickendinner1 Dec. 8 at 7:23 AM

$REVB can’t remember the other tickers now but tickers that have around the same m cap and same study which is CKD. They pumped at least 3x. Expecting the same here. Hope that happens

0 · Reply

Greyghost013 Dec. 4 at 6:57 PM

$REVB zero volume but inching up. Interesting 🤔

1 · Reply

Zstock1981 Dec. 4 at 3:56 PM

$REVB next $CAPR

1 · Reply

revuelto Dec. 4 at 12:06 AM

$REVB good things come to those who wait…sell the spike, then short it.…for anyone looking to profit both ways, this is the setup 😀

1 · Reply

Market Cap	5.10M
Revenue (ttm)	0.00
Net Income (ttm)	-15.04M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	27,600
Avg Vol	116,900
Day's Range	N/A - N/A
Shares Out	5.92M
Stochastic %K	6%
Beta	-0.11
Analysts	Strong Sell
Price Target	$21.25